( September 10, 2026, 08:37 GMT | Official Statement) -- MLex Summary: New AI tools in UK healthcare should be subject to a staged rollout and continuous monitoring, according to recommendations published on Thursday. This follows a 2025 consultation on the safe rollout of medical AI tools already in use for voice-enabled technologies, for early detection of skin cancers and other applications. The National Commission into the Regulation of AI in Healthcare also suggests giving stronger enforcement powers to the Medicines and Healthcare products Regulatory Agency, and giving the public easy access to information about the devices, including any incidents.Statement follows, report is attached....
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.